{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:44:17Z","timestamp":1767624257522},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4 Part 1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.juro.2015.10.065","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T16:25:45Z","timestamp":1445790345000},"page":"1051-1056","source":"Crossref","is-referenced-by-count":69,"title":["Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie\u2019s Disease"],"prefix":"10.1097","volume":"195","author":[{"given":"Matthew J.","family":"Ziegelmann","sequence":"first","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyd R.","family":"Viers","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly L.","family":"McAlvany","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George C.","family":"Bailey","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua B.","family":"Savage","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Landon W.","family":"Trost","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2015.10.065_bib1","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000049830","article-title":"Peyronie\u2019s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years","volume":"40","author":"LaPera","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib3","doi-asserted-by":"crossref","first-page":"282503","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie\u2019s disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-5347(17)37988-0","article-title":"The\u00a0incidence of Peyronie\u2019s disease in Rochester, Minnesota, 1950 through 1984","volume":"146","author":"Lindsay","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib5","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1111\/j.1743-6109.2012.02868.x","article-title":"The prevalence of Peyronie\u2019s disease in Japan: a study in men undergoing maintenance hemodialysis and routine health checks","volume":"9","author":"Shiraishi","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.10.065_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie\u2019s disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.juro.2015.10.065_bib7","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1743-6109.2009.01655.x","article-title":"Peyronie\u2019s disease following radical prostatectomy: incidence and predictors","volume":"7","author":"Tal","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.10.065_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11934-014-0415-4","article-title":"Update on medical management of Peyronie\u2019s disease","volume":"15","author":"Tan","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2015.10.065_bib9","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie\u2019s disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11934-014-0446-x","article-title":"Surgical management of Peyronie\u2019s disease","volume":"15","author":"Zaid","year":"2014","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.juro.2015.10.065_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bju.13096","article-title":"Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie\u2019s disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies","volume":"116","author":"Lipshultz","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.065_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie\u2019s disease: a phase 3 open-label study","volume":"12","author":"Levine","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.10.065_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jsm.12337","article-title":"Concordance between patient and physician assessment of the magnitude of Peyronie\u2019s disease curvature","volume":"11","author":"Matsushita","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.10.065_bib15","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/jsm.12721","article-title":"Surgical correction of persistent Peyronie\u2019s disease following collagenase clostridium histolyticum treatment","volume":"12","author":"Levine","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2015.10.065_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1756287212454932","article-title":"Penile traction therapy and Peyronie\u2019s disease: a state of art review of the current literature","volume":"5","author":"Chung","year":"2013","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.juro.2015.03.092","article-title":"The effect of duration of penile traction therapy in patients undergoing intralesional injection therapy for Peyronie\u2019s disease","volume":"194","author":"Yafi","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2015.10.065_bib19","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/bju.13120","article-title":"Analysis of the clinical safety of intralesional injection of collagenase Clostridium histolyticum (CCH) for adults with Peyronie\u2019s disease (PD)","volume":"116","author":"Carson","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2015.10.065_bib20","first-page":"2115","article-title":"An analysis of the natural history of Peyronie\u2019s disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J\u00a0Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715050028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534715050028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2015.10.065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T04:05:41Z","timestamp":1651205141000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2015.10.065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":20,"journal-issue":{"issue":"4 Part 1","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.1016\/j.juro.2015.10.065"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2015.10.065","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}